QIAGEN - 27 Year Stock Price History | QGEN
Historical daily share price chart and data for QIAGEN since 1996 adjusted for splits. The latest closing stock price for QIAGEN as of May 30, 2023 is 45.29.
- The all-time high QIAGEN stock closing price was 59.59 on July 17, 2000.
- The QIAGEN 52-week high stock price is 51.18, which is 13% above the current share price.
- The QIAGEN 52-week low stock price is 40.38, which is 10.8% below the current share price.
- The average QIAGEN stock price for the last 52 weeks is 46.62.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
QIAGEN Historical Annual Stock Price Data |
Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
2023 |
46.9750 |
49.9300 |
50.7700 |
43.9300 |
45.2900 |
-9.18% |
2022 |
46.9364 |
54.3000 |
54.3000 |
40.9000 |
49.8700 |
-10.27% |
2021 |
51.7858 |
53.3100 |
56.8300 |
46.2500 |
55.5800 |
5.17% |
2020 |
44.6405 |
33.9300 |
54.7400 |
33.1700 |
52.8500 |
56.36% |
2019 |
37.0654 |
34.1300 |
43.1000 |
25.4100 |
33.8000 |
-1.89% |
2018 |
35.1436 |
31.3600 |
39.3900 |
31.0100 |
34.4500 |
11.38% |
2017 |
31.4871 |
29.3054 |
35.3700 |
27.8100 |
30.9300 |
6.30% |
2016 |
25.1400 |
27.7373 |
29.7208 |
20.9665 |
29.0977 |
1.34% |
2015 |
26.4019 |
24.2688 |
29.2950 |
23.1681 |
28.7135 |
17.86% |
2014 |
23.9170 |
24.4350 |
26.1485 |
20.7796 |
24.3623 |
-1.47% |
2013 |
21.6478 |
19.5023 |
25.5981 |
19.1596 |
24.7258 |
31.19% |
2012 |
17.4983 |
14.7046 |
19.9385 |
14.7046 |
18.8479 |
31.42% |
2011 |
17.9325 |
20.6135 |
22.8773 |
13.1365 |
14.3412 |
-29.36% |
2010 |
21.1582 |
23.5315 |
24.9023 |
17.6746 |
20.3019 |
-12.45% |
2009 |
19.5703 |
17.7681 |
24.0196 |
15.4004 |
23.1888 |
27.16% |
2008 |
20.1357 |
22.5969 |
24.2896 |
13.4065 |
18.2354 |
-16.58% |
2007 |
18.9271 |
16.2415 |
24.4558 |
15.9092 |
21.8596 |
39.13% |
2006 |
14.8951 |
12.5031 |
16.7712 |
12.1708 |
15.7119 |
28.77% |
2005 |
12.6618 |
11.4542 |
14.2996 |
10.9662 |
12.2019 |
7.31% |
2004 |
12.0103 |
12.7938 |
16.2104 |
9.0762 |
11.3712 |
-8.44% |
2003 |
9.1969 |
5.6908 |
13.3442 |
5.4000 |
12.4200 |
130.44% |
2002 |
11.3746 |
19.7515 |
21.6104 |
4.6835 |
5.3896 |
-72.04% |
2001 |
23.1768 |
36.3462 |
36.7408 |
12.8562 |
19.2738 |
-46.34% |
2000 |
41.6247 |
21.2885 |
59.5869 |
19.5361 |
35.9204 |
83.26% |
1999 |
11.2356 |
8.5024 |
21.6779 |
8.5024 |
19.6010 |
150.62% |
1998 |
7.6380 |
5.8258 |
9.8654 |
5.4363 |
7.8209 |
35.03% |
1997 |
5.2753 |
3.2945 |
7.6587 |
3.1478 |
5.7920 |
73.28% |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Biomedical and Genetics |
$10.491B |
$2.142B |
QIAGEN N.V. is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids DNA/RNA. The company provides innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. It has developed a comprehensive portfolio of proprietary, consumable products, and automated solutions for sample collection. Qiagen has subsidiaries several other countries with good sales potential. Segment Details Consumables: These are typically sample preparation or test kits that contain all the necessary reagents and buffers, and a manual including protocols and relevant background information. Automated Instruments: These automate the use of Sample & Assay Technologies into efficient solutions for a broad range of laboratory needs. Customer Classes: QIAGEN focuses on 4 principal segments or customer classes for sample and assay technologies:? Molecular Diagnostics, Applied Testing, Pharma and Academia.
|